Diligent Announces Shiza Shahid, Moisés Naím, Michael Montelongo, Veena Ramani and More to Deliver Impactful Sessions at the Fourth Annual Modern Governance Summit
14.9.2022 21:37:00 EEST | Business Wire | Press release
Diligent, the global leader in modern governance providing SaaS solutions across governance, risk, compliance, audit and ESG, today announced keynote speakers and agenda highlights for its annual Modern Governance Summit (MGS), taking place in Austin, Texas and online between September 12-14, 2022.
World-renowned leaders will take the stage to explore key issues like risk and strategy; ethics and compliance; environmental, social and corporate governance (ESG); digital transformation and more. Attendees will have the opportunity to network with peers and hear from industry experts in impactful sessions like “The World Hangs in the Balance: Getting ESG Right”; “Living Your Purpose: Putting Your Values and Ethics First in Business”; “The Evolving Risk Landscape – Implications of Geopolitical and Financial Risk”; “What Has Changed (and what hasn't) Since SOX”; and “The Courage to Lead: What it Takes to Build a Purpose-Driven Enterprise.” A full agenda can be found here.
Just a few of the inspirational speakers at this year’s MGS include:
- Shiza Shahid, an entrepreneur, investor, technologist, and impact leader, co-founded the Malala Fund with Nobel Prize winner Malala Yousafzai and led the organization as founding CEO. She is now the co-founder of Our Place, a mission-driven e-commerce startup that is creating products and telling stories that celebrate cultural traditions and reinvest in communities, through the lens of food and home-cooking. Shiza will deliver a session on putting values and ethics first in business.
- Moisés Naím, internationally syndicated columnist and best-selling author. In the early 1990s, Dr. Naím served as Venezuela’s Minister of Trade and Industry, as director of Venezuela’s Central Bank, and as executive director of the World Bank. Dr. Naím will be a keynote speaker discussing geopolitical risk and strategy.
- Sherron Watkins, former Vice President of Corporate Development at the Enron Corporation, whose exposure of corporate misconduct paved the way for the enactment of SOX corporate reform law. Sherron will be part of a panel discussion on what has changed – and what hasn’t – since Sarbanes-Oxley Act was enacted 20 years ago.
- Cynthia Cooper, accountant who formerly served as the Vice President of Internal Audit at WorldCom where her team exposed the largest accounting fraud in U.S. history. Cynthia will also be part of the panel on what has changed since SOX.
- The Honorable Michael Montelongo, President and CEO of GRC Advisory Services, LLC, and former Bush White House appointee who served as the 19th assistant secretary for financial management and CFO of the US Air Force and the first Latino in that role. Michael will join Cynthia Cooper and Sherron Watkins in the SOX panel discussion.
- Veena Ramani, Research Director at FCLTGlobal and expert in corporate governance, climate change and ESG issues. Veena will be part of panel discussions on preparing for shareholder and stakeholder ESG activism and getting ESG right.
- Enrique Acevedo, CBS Correspondent who has interviewed some of the world’s biggest leaders, including President Barack Obama, Melinda Gates, Kofi Annan and more. Enrique will moderate “The World Hangs in the Balance: Getting ESG Right.”
“Organizations today are navigating complex and ever-evolving business landscapes, where uncertainty is omnipresent,” said Brian Stafford, CEO of Diligent. “In this era, the role of governance, risk, compliance, audit and ESG professionals has become even more critical. We’re honored to be engaging with this community of leaders in person once again as we explore the intersection of performance, risk and purpose, and to welcome this year’s roster of world-renowned speakers.”
Now in its fourth year, the Modern Governance Summit is the largest governance, risk and compliance (GRC) event of the year bringing together thousands of leaders from board members to corporate secretaries, general counsels, chief compliance officers and other governance professionals. Designed to elevate GRC practices and explore key issues facing organizations today, attendees benefit from 2.5 days of thought leadership, networking and product training opportunities.
The event is open to the press and most sessions will be on the record. For more information and to register contact: press@diligent.com
About Diligent
Diligent is the global leader in modern governance, providing SaaS solutions across governance, risk, compliance, audit and ESG. Serving more than 1 million users from over 25,000 customers around the world, we empower transformational leaders with software, insights and confidence to drive greater impact and lead with purpose. Learn more at diligent.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005247/en/
Contact information
Media Contact
Julia Hanbury
Senior Communications Manager, Diligent
+1-604-669-4225
Jhanbury@diligent.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 15:23:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
